Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study.

We assessed the persistence of hepatitis B surface antigen antibody (anti-HBs) and immune memory in a cohort of 571 teenagers vaccinated against hepatitis B as infants, 17 years earlier. Vaccinees were followed-up in 2003 and in 2010 (i.e. 10 years and 17 years after primary vaccination, respectively). When tested in 2003, 199 vaccinees (group A) had anti-HBs <10 mIU/mL and were boosted, 372 (group B) were not boosted because they had anti-HBs ≥10 mIU/mL (n = 344) or refused booster (n = 28) despite anti-HBs <10 mIU/mL. In 2010, 72.9% (416/571) of participants had anti-HBs ≥10 mIU/mL (67.3% in group A vs. 75.8% in group B; p 0.03). The geometric mean concentrations (GMCs) were similar in both groups. Between 2003 and 2010, anti-HBs concentrations in previously boosted individuals markedly declined with GMC dropping from 486 to 27.7 mIU/mL (p <0.001). Fifteen vaccinees showed a marked increase of antibody, possibly due to natural booster. In 2010, 96 individuals (37 of group A and 59 of group B) with anti-HBs <10 mIU/mL were boosted; all vaccinees of the former group and all but two of the latter had an anamnestic response. Post-booster GMC was higher in group B (895.6 vs. 492.2 mIU/mL; p 0.039). This finding shows that the immune memory for HBsAg persists beyond the time at which anti-HBs disappears, conferring long-term protection.

[1]  P. van Damme,et al.  Two decades of hepatitis B vaccination in mentally retarded patients: effectiveness, antibody persistence and duration of immune memory. , 2012, Vaccine.

[2]  Min Zhang,et al.  Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high. , 2011, Vaccine.

[3]  J. Tvrdík,et al.  Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up , 2010, Infection.

[4]  Chien-Jen Chen,et al.  Determination of immune memory to hepatitis B vaccination through early booster response in college students , 2010, Hepatology.

[5]  A. Theamboonlers,et al.  Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. , 2010, Vaccine.

[6]  Thomas W. Hennessy,et al.  Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. , 2009, The Journal of infectious diseases.

[7]  P. De Wals,et al.  Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later. , 2009, Vaccine.

[8]  A. Theamboonlers,et al.  Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers. , 2009, The Journal of infectious diseases.

[9]  M. Yuen,et al.  Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. , 2008, Vaccine.

[10]  P. van Damme,et al.  The global impact of vaccination against hepatitis B: a historical overview. , 2008, Vaccine.

[11]  Ryan T Novak,et al.  Persistence of Protection Against Hepatitis B Virus Infection Among Adolescents Vaccinated With Recombinant Hepatitis B Vaccine Beginning at Birth: A 15-Year Follow-Up Study , 2008, The Pediatric infectious disease journal.

[12]  K. Herck,et al.  Benefits of Early Hepatitis B Immunization Programs for Newborns and Infants , 2008, The Pediatric infectious disease journal.

[13]  Mei-Hwei Chang,et al.  Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. , 2008, The Journal of infectious diseases.

[14]  P. Lopalco,et al.  Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Chung-Yi Li,et al.  Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. , 2007, Vaccine.

[16]  A. Zanetti,et al.  Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. , 2007, Vaccine.

[17]  P. Lopalco,et al.  Erratum: Acute delta hepatitis in Italy: Incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign (Clinical Infectious Diseases (2007) 44 (e17-24)) , 2007 .

[18]  P. Lopalco,et al.  Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  A. Zanetti,et al.  Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study , 2005, The Lancet.

[20]  B. McMahon,et al.  Differences in Response to a Hepatitis B Vaccine Booster Dose Among Alaskan Children and Adolescents Vaccinated During Infancy , 2005, Pediatrics.

[21]  B. McMahon,et al.  Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. , 2005, Vaccine.

[22]  P. De Wals,et al.  Comparative Long Term Immunogenicity of Two Recombinant Hepatitis B Vaccines and the Effect of a Booster Dose Given After Five Years in a Low Endemicity Country , 2005, The Pediatric infectious disease journal.

[23]  M. Yuen,et al.  18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  D. Kelly,et al.  Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. , 2004, The Journal of infectious diseases.

[25]  H. Margolis,et al.  Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. , 2001, Vaccine.

[26]  P. van Damme,et al.  Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. , 2000, Vaccine.

[27]  B. McMahon,et al.  Increases in levels of antibody to hepatitis B surface antigen in an immunized population. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  E. Tanzi,et al.  Vaccination against hepatitis B: the Italian strategy. , 1993, Vaccine.

[29]  N. Abrescia,et al.  MASS VACCINATION AGAINST HEPATITIS B IN INFANTS IN ITALY , 1988, The Lancet.